0
Letters to the Editor   |    
Age Bias and Choice of Intervention for Treatment of Avascular Necrosis
J. D. Witt, F.R.C.S., F.R.C.S.(Orth); Sean P. Scully, M.D.Ph.D.
View Disclosures and Other Information
Department of Orthopaedic Surgery, The Middlesex Hospital, Mortimer Street, London W1N 8AA, United Kingdom
Division of Orthopaedic Surgery, Musculoskeletal Oncology Section, Duke University Medical Center, Box 3312, Durham, North Carolina 27710, E-mail address: scull002@mc.duke.edu

The Journal of Bone & Joint Surgery.  2000; 82:1804-a-1804 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case
To The Editor:
Regarding the article "Survival Analysis of Hips Treated with Core Decompression or Vascularized Fibular Grafting Because of Avascular Necrosis" (80-A: 1270-1275, Sept. 1998), by Scully et al., I am not certain that, from the data presented, firm conclusions can be made when comparing these two treatment modalities. The main reasons for this are the significant age differences of patients in the Ficat stage-II and stage-III groups and the end point the authors have chosen for failure - conversion to total hip arthroplasty.
No clinical data are presented in terms of pain scores or functional evaluation of patients, and, therefore, one cannot say that the threshold for total hip arthroplasty is the same in the two groups of patients. Indeed, the threshold for performing a total hip arthroplasty in the older patient is likely to be much lower. The paper gives no indication that consistent criteria were applied to determine when a patient should undergo arthroplasty, and this determination can, of course, completely change the outcome of the study.
To apply a Cox proportional-hazards model to demonstrate the absence of age bias when the structure of the study is flawed in this way is misleading.
J. D. Witt, F.R.C.S., F.R.C.S.(Orth)
Department of Orthopaedic Surgery The Middlesex Hospital Mortimer Street London W1N 8AA, United Kingdom
S. P. Scully replies:
Mr. Witt raises the concern that, because of the age differences between the core decompression and vascularized fibular graft populations, a bias may be introduced when conversion to total hip arthroplasty is used as an end point. He also raises the concern that younger patients may be less likely to undergo the conversion operation. When we recognized that there was a statistical difference in ages between the two populations, we were aware of the bias that this may introduce. Clinical criteria were used on an individual basis in both study populations to determine when arthroplasty was to be chosen as an intervention. While some bias may have been introduced during the clinical decision-making process, there was no means of eliminating this, as ours was a retrospective study. The Cox proportional-hazards model was one means that we used to isolate the influence of the age variable on the outcomes in the two populations.
In the published Kaplan-Meier plots, the time for 50 percent of the failures to occur in stage-III disease was approximately twenty-one months for the vascularized fibular graft group compared with fifteen months for the core decompression group. In a subsequent publication, a similar number was reported for an unrelated group of patients treated with core decompression1. That would suggest that bias may be introduced either because of age or because of the emotional investment in the larger procedure, as has already been discussed2-4. A prospective, randomized study would eliminate these biases, but, in the absence of such data, our study serves as an initial attempt to evaluate the efficacy of the vascularized fibular grafting procedure by comparing it with an accepted intervention for this disease process.
Sean P. Scully, M.D., Ph.D.
Division of Orthopaedic Surgery Musculoskeletal Oncology Section Duke University Medical Center, Box 3312 Durham, North Carolina 27710 E-mail address: scull002@mc.duke.edu
Bozic, K. J.; Zurakowski, D.; and Thornhill, T. S.: Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head. J. Bone and Joint Surg.,81-A: 200-209, Feb 1999.81-A200  1999 
 
Chillag, K. J.: Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis [letter. J. Bone and Joint Surg.,82-A: 289-290, Feb 2000.82-A289  2000 
 
Goodman, S. B.: Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis [letter. J. Bone and Joint Surg.,82-A: 289, Feb 2000.82-A289  2000 
 
Mont, M. A.; Jones, L. C.; and Hungerford, D. S.: Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis [letter]. J. Bone and Joint Surg.,82-A: 290-291, Feb 2000.82-A290  2000 
 

Submit a comment

Topics

Bozic, K. J.; Zurakowski, D.; and Thornhill, T. S.: Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head. J. Bone and Joint Surg.,81-A: 200-209, Feb 1999.81-A200  1999 
 
Chillag, K. J.: Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis [letter. J. Bone and Joint Surg.,82-A: 289-290, Feb 2000.82-A289  2000 
 
Goodman, S. B.: Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis [letter. J. Bone and Joint Surg.,82-A: 289, Feb 2000.82-A289  2000 
 
Mont, M. A.; Jones, L. C.; and Hungerford, D. S.: Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis [letter]. J. Bone and Joint Surg.,82-A: 290-291, Feb 2000.82-A290  2000 
 
Accreditation Statement
These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
CME Activities Associated with This Article
Submit a Comment
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe




Related Articles
Related Cases
Related Content
Topic Collections
Related Audio and Videos
PubMed Articles
Clinical Trials
Readers of This Also Read...
jbjs jobs
12/22/2011
VA - Charleston Area Medical Center
12/22/2011
ME - Central Maine Medical Center